Subretinal Fluid associated with Drusenoid Pigment Epithelial Detachment.
Sign Up to like & getrecommendations! Published in 2023 at "Retina"
DOI: 10.1097/iae.0000000000003800
Abstract: PURPOSE To analyze the clinical characteristics of drusenoid pigment epithelial detachment (PED) with subretinal fluid (SRF) and to evaluate the impact of SRF on the long-term visual and anatomical outcomes. METHODS Forty-seven eyes with drusenoid… read more here.
Keywords: pigment epithelial; development; srf; drusenoid pigment ... See more keywords
Photobiomodulation therapy for large soft drusen and drusenoid pigment epithelial detachment in age-related macular degeneration: a single-center prospective pilot study.
Sign Up to like & getrecommendations! Published in 2023 at "Retina"
DOI: 10.1097/iae.0000000000003805
Abstract: PURPOSE To evaluate visual acuity and morphologic changes after photobiomodulation (PBM) for patients affected with large soft drusen and/or drusenoid pigment epithelial detachment (dPED) associated to dry age-related macular degeneration (AMD). METHOD Twenty eyes with… read more here.
Keywords: pigment epithelial; large soft; drusen drusenoid; soft drusen ... See more keywords
Efficacy and safety of brolucizumab for serous drusenoid pigment epithelium detachment non-responder to bevacizumab and aflibercept.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of ophthalmology"
DOI: 10.1177/11206721221143154
Abstract: INTRODUCTION We report the case of a woman with drusenoid pigment epithelial detachment (DPED) in age-related macular degeneration who was successfully treated with two monthly intravitreal injections of brolucizumab after failing to respond to previous… read more here.
Keywords: subretinal fluid; bevacizumab aflibercept; intravitreal injections; drusenoid pigment ... See more keywords